Trials / Unknown
UnknownNCT04681014
CTEPH in Patients With Prior Pulmonary Embolism and Risk Score Validation
Evidence-based Detection of CTEPH in Patients With Prior Pulmonary Embolism: Risk Score Evaluation and Validation.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,218 (actual)
- Sponsor
- iPHNET (italian Pulmonary Hypertension NETwork) · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
CTEPH-SOLUTION aims to create a risk score for the early detection of Chronic Thrombo-Embolic Pulmonary Hypertension (CTEPH) among patients with previous pulmonary embolism. The risk score, created on retrospective data, will be validated on newly diagnosed pulmonary embolism patients.
Detailed description
CTEPH-SOLUTION is a multicenter observational cross-sectional and prospective study in patients with a prior and new diagnosis of pulmonary embolism. Patients with prior pulmonary embolism will be screened at baseline with doppler echocardiography: an estimated sPAP ≥ 40 mmHg will be the indication for pulmonary hypertension detection. After 24 months from baseline, patients will be followed-up for CTEPH detection. CTEPH diagnosis will be carried out according to the current ESC/ERS guidelines. Incident (pulmonary embolism episode at least three months before the baseline) and prevalent (pulmonary embolism episode) patients will be enrolled.
Conditions
Timeline
- Start date
- 2016-01-21
- Primary completion
- 2020-07-31
- Completion
- 2022-07-31
- First posted
- 2020-12-23
- Last updated
- 2020-12-23
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04681014. Inclusion in this directory is not an endorsement.